Cell Growth & Differentiation, Vol 1, Issue 2 87-95, Copyright © 1990 by American Association of Cancer Research

ARTICLES

Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene

A Iyer, TE Kmiecik, M Park, I Daar, D Blair, KJ Dunn, P Sutrave, JN Ihle, M Bodescot and GF Vande Woude
Rush Presbyterian St. Luke's Medical Center, Medical Oncology Department, Chicago, Illinois 60612.

A 6.7-kilobase met complementary DNA (cDNA) was isolated from a pcD cDNA library prepared from C3H mouse fibroblast cell line polyadenylated RNA. Sequence analysis of 6.7-kilobase met cDNA insert revealed that it contained the entire open reading frame and shared an overall homology of 88.1% with the human met gene. Using the mouse met cDNA as probe, high levels of met expression were observed in the kidney, brain, lung, skin, and embryonic tissue as well as in several factor responsive mouse myeloid cell lines. Under SV40 promoter control, the mouse met protooncogene cDNA in the pCD vector was able to transform NIH 3T3 cells. These transformed cells possess multiple copies of mouse met cDNA and exhibit properties of malignant cells, including growth in soft agar and induction of tumors in nude mice. Tumor explant cell lines analyzed by Western blot also reveal the presence of high levels of Mr 170,000 and 140,000 met protein product(s).

This article has been cited by other articles:

				C. N. Wrobel, J. Debnath, E. Lin, S. Beausoleil, M. F. Roussel, and J. S. Brugge Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture J. Cell Biol., April 26, 2004; 165(2): 263 - 273. [Abstract] [Full Text] [PDF]

				R. V. Hay, B. Cao, R. S. Skinner, L.-M. Wang, Y. Su, J. H. Resau, B. S. Knudsen, M. F. Gustafson, H.-M. Koo, G. F. V. Woude, et al. Radioimmunoscintigraphy of Human Met-Expressing Tumor Xenografts Using Met3, a New Monoclonal Antibody Clin. Cancer Res., September 1, 2003; 9(10): 3839S - 3844. [Abstract] [Full Text] [PDF]

				J. A. Recio, F. P. Noonan, H. Takayama, M. R. Anver, P. Duray, W. L. Rush, G. Lindner, E. C. De Fabo, R. A. DePinho, and G. Merlino Ink4a/Arf Deficiency Promotes Ultraviolet Radiation-induced Melanomagenesis Cancer Res., November 15, 2002; 62(22): 6724 - 6730. [Abstract] [Full Text] [PDF]

				A. Catizone, G. Ricci, and M. Galdieri Functional Role of Hepatocyte Growth Factor Receptor During Sperm Maturation J Androl, November 1, 2002; 23(6): 911 - 918. [Abstract] [Full Text] [PDF]

				Y. Yu and G. Merlino Constitutive c-Met Signaling through a Nonautocrine Mechanism Promotes Metastasis in a Transgenic Transplantation Model Cancer Res., May 1, 2002; 62(10): 2951 - 2956. [Abstract] [Full Text] [PDF]

				G. Maulik, T. Kijima, P. C. Ma, S. K. Ghosh, J. Lin, G. I. Shapiro, E. Schaefer, E. Tibaldi, B. E. Johnson, and R. Salgia Modulation of the c-Met/Hepatocyte Growth Factor Pathway in Small Cell Lung Cancer Clin. Cancer Res., February 1, 2002; 8(2): 620 - 627. [Abstract] [Full Text] [PDF]

				K. A. Furge, D. Kiewlich, P. Le, M. N. Vo, M. Faure, A. R. Howlett, K. E. Lipson, G. F. Vande Woude, and C. P. Webb Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase PNAS, September 4, 2001; (2001) 191067898. [Abstract] [Full Text] [PDF]

				G. A. Gmyrek, M. Walburg, C. P. Webb, H.-M. Yu, X. You, E. D. Vaughan, G. F. Vande Woude, and B. S. Knudsen Normal and Malignant Prostate Epithelial Cells Differ in Their Response to Hepatocyte Growth Factor/Scatter Factor Am. J. Pathol., August 1, 2001; 159(2): 579 - 590. [Abstract] [Full Text]

				R. Wang, L. D. Ferrell, S. Faouzi, J. J. Maher, and J. M. Bishop Activation of the Met Receptor by Cell Attachment Induces and Sustains Hepatocellular Carcinomas in Transgenic Mice J. Cell Biol., May 29, 2001; 153(5): 1023 - 1034. [Abstract] [Full Text] [PDF]

				A. Catizone, G. Ricci, and M. Galdieri Expression and Functional Role of Hepatocyte Growth Factor Receptor (C-MET) during Postnatal Rat Testis Development Endocrinology, May 1, 2001; 142(5): 1828 - 1834. [Abstract] [Full Text]

				T. Otsuka, J. Jakubczak, W. Vieira, D. P. Bottaro, D. Breckenridge, W. J. Larochelle, and G. Merlino Disassociation of Met-Mediated Biological Responses In Vivo: the Natural Hepatocyte Growth Factor/Scatter Factor Splice Variant NK2 Antagonizes Growth but Facilitates Metastasis Mol. Cell. Biol., March 15, 2000; 20(6): 2055 - 2065. [Abstract] [Full Text]

				T. Nagahori, M. Dohi, K. Matsumoto, K. Saitoh, Z.-I. Honda, T. Nakamura, and K. Yamamoto Interferon-gamma Upregulates the c-Met/Hepatocyte Growth Factor Receptor Expression in Alveolar Epithelial Cells Am. J. Respir. Cell Mol. Biol., October 1, 1999; 21(4): 490 - 497. [Abstract] [Full Text]

				S. Koochekpour, M. Jeffers, P. H. Wang, C. Gong, G. A. Taylor, L. M. Roessler, R. Stearman, J. R. Vasselli, W. G. Stetler-Stevenson, W. G. Kaelin Jr., et al. The von Hippel-Lindau Tumor Suppressor Gene Inhibits Hepatocyte Growth Factor/Scatter Factor-Induced Invasion and Branching Morphogenesis in Renal Carcinoma Cells Mol. Cell. Biol., September 1, 1999; 19(9): 5902 - 5912. [Abstract] [Full Text] [PDF]

				A. Catizone, G. Ricci, V. Arista, A. Innocenzi, and M. Galdieri Hepatocyte Growth Factor and c-MET Are Expressed in Rat Prepuberal Testis Endocrinology, July 1, 1999; 140(7): 3106 - 3113. [Abstract] [Full Text]

				T. Tamatani, K. Hattori, A. Iyer, K. Tamatani, and R. Oyasu Hepatocyte growth factor is an invasion/migration factor of rat urothelial carcinoma cells in vitro Carcinogenesis, June 1, 1999; 20(6): 957 - 962. [Abstract] [Full Text] [PDF]

				O. Bögler, M. Nagane, J. Gillis, H-J. Su Huang, and W. K. Cavenee Malignant Transformation of p53-deficient Astrocytes Is Modulated by Environmental Cues in Vitro Cell Growth Differ., February 1, 1999; 10(2): 73 - 86. [Abstract] [Full Text]

				D. Ronen, R. T. Altstock, M. Firon, L. Mittelman, T. Sobe, J. H. Resau, G. F. Vande Woude, and I. Tsarfaty Met-HGF/SF Mediates Growth Arrest and Differentiation in T47D Breast Cancer Cells Cell Growth Differ., February 1, 1999; 10(2): 131 - 140. [Abstract] [Full Text]

				M. Jeffers, M. Fiscella, C. P. Webb, M. Anver, S. Koochekpour, and G. F. Vande Woude The mutationally activated Met receptor mediates motility and metastasis PNAS, November 24, 1998; 95(24): 14417 - 14422. [Abstract] [Full Text] [PDF]

				C. P. Webb, L. Van Aelst, M. H. Wigler, and G. F. Vande Woude Signaling pathways in Ras-mediated tumorigenicity and metastasis PNAS, July 21, 1998; 95(15): 8773 - 8778. [Abstract] [Full Text] [PDF]

				C.-Z. Yu, H. Hisha, Y. Li, Z. Lian, T. Nishino, J. Toki, Y. Adachi, M. Inaba, T.-X. Fan, T. Jin, et al. Stimulatory Effects of Hepatocyte Growth Factor on Hemopoiesis of SCF/c-kit System-Deficient Mice Stem Cells, January 1, 1998; 16(1): 66 - 77. [Abstract] [Full Text]

				M. Jeffers, L. Schmidt, N. Nakaigawa, C. P. Webb, G. Weirich, T. Kishida, B. Zbar, and G. F. Vande Woude Activating mutations for the Met tyrosine kinase receptor in human cancer PNAS, October 14, 1997; 94(21): 11445 - 11450. [Abstract] [Full Text] [PDF]

				S. Anastasi, S. Giordano, O. Sthandier, G. Gambarotta, R. Maione, P. Comoglio, and P. Amati A Natural Hepatocyte Growth Factor/Scatter Factor Autocrine Loop in Myoblast Cells and the Effect of the Constitutive Met Kinase Activation on Myogenic Differentiation J. Cell Biol., June 2, 1997; 137(5): 1057 - 1068. [Abstract] [Full Text] [PDF]

				H. Takayama, W. J. LaRochelle, R. Sharp, T. Otsuka, P. Kriebel, M. Anver, S. A. Aaronson, and G. Merlino Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor PNAS, January 21, 1997; 94(2): 701 - 706. [Abstract] [Full Text] [PDF]

				X. Yang, K Vogan, P Gros, and M Park Expression of the met receptor tyrosine kinase in muscle progenitor cells in somites and limbs is absent in Splotch mice Development, July 1, 1996; 122(7): 2163 - 2171. [Abstract] [PDF]

				C. Webb, K Lane, A. Dawson, G. Vande Woude, and R. Warn C-Met signalling in an HGF/SF-insensitive variant MDCK cell line with constitutive motile/invasive behaviour J. Cell Sci., January 9, 1996; 109(9): 2371 - 2381. [Abstract] [PDF]

				J. Soriano, M. Pepper, T Nakamura, L Orci, and R Montesano Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells J. Cell Sci., January 2, 1995; 108(2): 413 - 430. [Abstract] [PDF]

				I Tsarfaty, S Rong, J. Resau, S Rulong, P. da Silva, and G. Vande Woude The Met proto-oncogene mesenchymal to epithelial cell conversion Science, January 7, 1994; 263(5143): 98 - 101. [Abstract] [PDF]

				I Tsarfaty, J. Resau, S Rulong, I Keydar, D. Faletto, and G. Vande Woude The met proto-oncogene receptor and lumen formation Science, August 28, 1992; 257(5074): 1258 - 1261. [Abstract] [PDF]

				D. Bottaro, J. Rubin, D. Faletto, A. Chan, T. Kmiecik, G. Vande Woude, and S. Aaronson Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product Science, February 15, 1991; 251(4995): 802 - 804. [Abstract] [PDF]

				K. A. Furge, D. Kiewlich, P. Le, M. N. Vo, M. Faure, A. R. Howlett, K. E. Lipson, G. F. V. Woude, and C. P. Webb Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase PNAS, September 11, 2001; 98(19): 10722 - 10727. [Abstract] [Full Text] [PDF]